chrisvoncsefalvay/vaers-outcomes huggingface dataset:
11 PM on 17th: Headache, Fever, Morning of 19th: Stuffed Nose, Coughing, Body Aches. Took Ibuprofen and DayQuil, mildly suppressed the symptoms, but headache stayed extreme until the 19th.
Swollen arm with a knot at the bottom part from elbow on up.  Later on the entire left side became swollen from neck to foot.  Stayed that way until 09/19/2021.
This spontaneous report has received from a medical assistant referring to multiple unspecified patients of unknown age and gender. No information was provided regarding the patients' medical history, concurrent conditions, drug and allergy history. On multiple unspecified dates, the patients were vaccinated with improperly stored doses VARIVAX lot # N017396, expiration date 07-JUN-2019, for prophylaxis. Concomitant therapies included sterile diluent (STERILE MRK). The doses of VARIVAX were exposed to a temperature excursion of 15°Fahrenheit (°F) to 46°F during a time frame of 1 hour and 23 minutes, which was detected by the data logger. There was a previous temperature excursion of 6°F to 14°F for 1 hour and 16 minutes. No adverse effects were reported.
A pregnant patient was administered with FLUZONE QUADRIVALENT 0.5 mL prefilled syringe and some of it leaked out where the needle was connecting to the syringe with no AE; some of it leaked out where the needle was connecting to the syringe. They are unable to determine how much vaccine that the patient has received with no AE; Initial information received on 12-Oct-2020 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 32 years old female patient who was exposed to vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] 0.5 ml prefilled syringe and some of it leaked out where the needle was connecting to the syringe and they are unable to determine how much vaccine that the   Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known.  They are unable to determine how much vaccine that the patient has received with no AE occurred at 35 weeks of pregnancy and the patient was exposed to INFLUENZA QUADRIVAL A-B VACCINE at 35 weeks of pregnancy, during third pregnancy trimester for INFLUENZA QUADRIVAL A-B VACCINE.  The date of last menstrual period was reported as 08-Feb-2020.  The estimated due date is 07-Dec-2020.  The patient's medical history, medical treatment(s), vaccination(s), family history and concomitant medication were not provided.  On 12-Oct-2020, the patient received a dose of suspect 0.5 ml INFLUENZA QUADRIVAL A-B VACCINE [lot UT7058JA and expiration date via intramuscular route in the left deltoid for prophylactic vaccination.  On same day, some of it leaked out where the needle was connecting to the syringe (Device connection issue) they are unable to determine how much vaccine that the patient has received (Underdose) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  No adverse event was reported.  It was not reported if the patient received a corrective treatment.  The outcome was reported as Not Applicable for both events.  Additionally, at time of reporting, the pregnancy is still ongoing.
I95.9 HYPOTENSION 6/24/2023 ESRD (END STAGE RENAL DISEASE) J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/22/2023 ESRD (END STAGE RENAL DISEASE) I95.9 HYPOTENSION 6/24/2023 ESRD (END STAGE RENAL DISEASE) J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/22/2023 ESRD (END STAGE RENAL DISEASE) I95.9 HYPOTENSION 6/24/2023 SEPSIS WO ACUTE ORGAN DYSFUNCTION J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/22/2023 SEPSIS WO ACUTE ORGAN DYSFUNCTION I95.9 HYPOTENSION 6/24/2023 RESPIRATOR DEPENDENCE J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/22/2023 RESPIRATOR DEPENDENCE I95.9 HYPOTENSION 6/24/2023 HYDRONEPHROSIS J96.92 HYPERCAPNIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 7/22/2023 HYDRONEPHROSIS
Patient is pregnant and is currently 39 weeks, was 37 at the time of immunization. Patient received flublock instead of tdap and states she had flulike symptoms after receiving the immunization. Normal side effects from receiving the flu shot, body aches, and muscle aches.
Child became pale then fainted after receiving flu shot; positioned on trendelenburg, V/S were taken, initial BP 100/60. RR 82; 11:15AM - 110/60; 11:25AM 100/60; then brought to the health office to call parents.
The day after the vaccine my face seemed to have a mild allergic reaction (painful to the touch). This lasted for 2 days. The day after the vaccine the lymph node under the left arm (where the vaccine had been given) was swollen and painful to the touch.
Patient stated he had pain in at the injection site beginning the day of immunization, sore muscle and muscle tightness. It was getting better a few days later then he re-aggrivated the arm. The patient reported the event 11/05/2019 while receiving medication prescribed to treat the adverse reaction.
Starting April 6 (date is best of my recollection but actual dates should be viewable in where I logged everything) I experienced 3-4 consecutive days of ocular migraines each morning. I have had a few (1-3) ocular migraines in my life but very rarely and never more than once every few years. This was followed by reoccurring tension headaches that increased in frequency and duration until constant. Vertigo started a week or two later and continued daily until yesterday 6/30/21 when I saw a physical therapist who was able to perform the Epiley Maneuver for BPPV in my left ear canal. This is not something I have ever had before.  I requested to see my doctor on Monday June 7th after two months of Vertigo and tension headaches that followed the ocular migraines. Symptoms themselves would have been manageable if temporary but the duration became concerning. I was prescribed and took a 5 day course of prednisone in case the headaches and resulting vertigo might have been related to a sinus infection. I was prescribed meclizine to help with the Vertigo and referred to PT.
PATIENT RECEIVED SECOND DOSE TOO SOON. INSTEAD OF DAY 28 IT WAS DAY 19 IN SERIES.
numb arm; little tired; just aching little bit in knee; I have red area that is red looking at the site; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 65 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 04Oct2021 08:30 (Lot number: FF8839) at the age of 65 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1), for Covid-19 immunization; Bnt162b2 (dose 2), for Covid-19 immunization. The following information was reported: FATIGUE (non-serious) with onset Oct2021, outcome "unknown", described as "little tired"; ARTHRALGIA (non-serious) with onset Oct2021, outcome "unknown", described as "just aching little bit in knee"; VACCINATION SITE ERYTHEMA (non-serious) with onset Oct2021, outcome "unknown", described as "I have red area that is red looking at the site"; HYPOAESTHESIA (non-serious), outcome "unknown", described as "numb arm". Therapeutic measures were not taken as a result of fatigue, arthralgia, vaccination site erythema, hypoaesthesia.  Additional information: It was reported that report not related to a study or program. In response to file the safety report, (Privacy) stated that she did not had a bad experience (incomplete sentence). She just want to see what she need to do about this numb arm. No prior vaccination was reported. Further probing could not be done as (Privacy) was unwilling to further answer the questions. Hence, other details were unknown and limited information was available over the call. She took the Booster Shot (COVID-19 Vaccine) on yesterday here at the Clinic and she felt still ok, just little tired, just aching little bit in knee, her joints and 'stuff' (Not clarified) when she came home today from work, she noticed that she had red area that was red looking at the site and it looked absolute 'rough' (Not clarified).  Causality: (Privacy) stated, "Yes because I am having it in my arm, yes."  Follow-up attempts are completed. No further information is expected
Systemic: Dizziness / Lightheadness-Medium, Systemic: Nausea-Medium, Systemic: Vomiting-Medium, Additional Details: pt developed vertigo and vomiting after recieving bivalent pfizer covid vaccine
Called to assist supervisor with client.  He had MMr, Varicella, Prevnar, & HepA around 10am.  About 10:10am a WIC nurse brought to supervisor's attention client had broken out in a rash.  A pinpoint red dot like rash was noted on cheeks bilaterally-paler, sparser dots on abdomen. Child seemed slightly pale. Per standing order at 10:12am 0.1ml epinephrine (1:1000) given IM based on weight of 22 pounds in Rt. vast lat. thigh, 911 called and here about 10:14am.  No shortness of breath, wheezing or respiratory distress noted.  Child and mom left per private car at 10:35am.  Mother was educated that child needed to be seen today and that epinephrine only lasts about 15 minutes.  Mom had an appointment with Dr. at 11am.  Rash noted to be more scarce and faded, but still visible slightly as pale raised areas on cheeks.  Color less pale. Mom left at 10:40am and Dr.'s office called at 10:42am. Report given to nurse and IM record faxed to office.  Chart tagged for possible allergy. Per mom's telephone report Dr. sent child to emergency room.  Mom reports they gave Benadryl 12.5mg and kept patient for several hours to observe reaction.  Mom states child had no further reactions.  She reports today child has a few red dots on face, and a small patch under right areola. Child alert, talking, no signs of repiratory distress per mom's report.  States child has an appointment with Dr. this Wednesday, April 9th for further tests.
Patient presented to ER with fever of 104, patient discharged to home and then presented to clinic on 08/09/2010 with cellulitis of right thigh.
PATIENT WAS GIVEN ANTHRAX VACCINE INSTEAD OF SEASONAL FLU. PATIENT WAS INSTRUCTED TO WAIT 20 MINUTES IN THE CLINIC, NO ADVERSE REACTION/SYMPTOMS NOTED. PATIENT TO FOLLOW UP IN CLINIC IN 1 WEEK. PATIENT HAD ANNUAL ANTHRAX BOOSTER 28 DAYS AGO.
Fever (101.2 degrees Fahrenheit). chills, headache, joint aches lasting approximately 36 hours
Small red bump on left thigh, seen again on 1/27/17 for no improvement.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old male patient received BNT162b2 (BNT162B2), on 30Nov2021 at 09:00 as dose 3 (booster), single (Lot number: 31130BA) at the age of 67 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 31May2022 at 15:00 as dose 4 (booster), single (Lot number: 037A22B), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: AMLODIPINE; ATORVASTATIN; HYDROCHLOROTHIAZIDE; CHOLESTYRAMINE LIGHT. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results, notes: Treatment of COVID-19; (10Jul2022) Negative. Therapeutic measures were taken as a result of drug ineffective, covid-19.
frozen shoulder/Freezing of his Shoulder; joint pain; lower back pain; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A 76-year-old male patient received rsv vaccine prot.subunit pref 2v (ABRYSVO), on 18Oct2023 as dose number unknown, 0.5 ml single (Lot number: HF5023, Expiration Date: Feb2025) at the age of 76 years intramuscular, in right arm and as dose number unknown, single (Lot number: HA3217, Expiration Date: Mar2025) for respiratory syncytial virus immunisation; for respiratory syncytial virus immunisation. The patient had no relevant medical history. Concomitant medication(s) included: MEDROL DOSEPAK. The following information was reported: PERIARTHRITIS (non-serious) with onset 2023, outcome "unknown", described as "frozen shoulder/Freezing of his Shoulder"; ARTHRALGIA (non-serious) with onset 2023, outcome "unknown", described as "joint pain"; BACK PAIN (non-serious) with onset 2023, outcome "unknown", described as "lower back pain". The information on the batch/lot number for rsv vaccine prot.subunit pref 2v  has been requested and will be submitted if and when received.
Child accompanied by mother for varicella vaccine for school entry.  Screening questions asked to mother, denied any allergies, medical conditions, fever, or previous reactions.  States child has not had chickenpox disease.  Vaccine re-constituted with 0.7ml stenlediluent and administered subcutaneously to left upper outer deltoid.  Tolerated injection well except stated it burns several times.  After approximately 5-6 minutes while mother was talking to nurse, patient states "I feel funny", face appeared pale.  Assisted to chair by nurse and mother when child suddenly slumped over and became unresponsive.  Immediately assisted to floor when child convulsed and back arched into a c-position with eyes closed and jerked several times.  Ambulance notified at this time incident lasted approximately 30-45 seconds.  No apnea or loss of bowel/bladder occurred.  Patient became responsive with no memory of incident and confusion.  Remained on floor in supine position - vs BP 80/60, p-48, r-16-20 uneven.  Color pale, skin remained warm and dry.  Ambulance arrived approximately 09:35AM.  Patient answered questions appropriately, transported to hospital via ambulance with mother.  Copy of vaccine label provided with lot number.  07/19/2005 Mom back in clinic today for TB med refill.  Inquired about child's  status.  States patient was released from hospital in stable condition with appointment for EEG and to see a neurologist RE: seizure.  Mom states she thinks this has been going on for a while, reports she just found out from patients friend that child had similar incident while hit in head while playing.  States child did vomit once at home and Mom states reported this to ER doctor.  States patient is fine however now.  Encouraged Mom to keep us informed on patient's status.
Employee presented the next day 3/3/11 with c/o tenderness, redness at injection site on (L) upper arm. Noted visible area of redness, slightly raised measuring 2x1 inch, warm to touch. Temp 99.7 orally. Instructed on TYLENOL, ice pak.
pt recv 2 doses of vax 4DEC95 & 12JAN96 & lab eval revealed a varicella antibody level of 0.05;no further details were provided;
Malaise, extreme shivering, and sweating. The sweating and shivering caused a syncopal episode and a fall.  Low grade arm pain.
PATIENT IS 4 YEARS OLD AND WAS GIVEN PFIZER BILVALENT 5-11 YRS OLD
Patient reports having a low grade fever around 99.6 degrees and severe chills.  Recommended Tylenol for treatment.
I want to report a side effect; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (I want to report a side effect) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-May-2021, the patient experienced VACCINATION COMPLICATION (I want to report a side effect). At the time of the report, VACCINATION COMPLICATION (I want to report a side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment medications were provided.
53 yo woman with no PMH was diagnosed with COVID-19 by PCR on 5/7/21. She had a mild illness with cough and fevers but did not require hospitalization. Her symptoms lasted about 1 week. She got her first dose of Pfizer COVID vaccine on 5/29 around 11 am. Within 4 hours (around 3 pm) she started to develop extreme fatigue, which she attributed to vaccine. This was followed by nausea, vomiting and diarrhea later that same day. The symptoms got worse on 5/30. Her diarrhea/GI symptoms resolved on 5/31. That day, she had a fever to 101.3. She continued to have fatigue, and started to have dyspnea, and presented to hospital on 6/1/21. On arrival to ED her vitals were 88/41, 36.1, 125, 18, 95% on RA (13:22). She become more hypotensive with nadir BP 63/48, HR 109 at 17:30, at which time she was started on norepinephrine. Physical exam at admission was notable for clear lungs, tenderness to palpation in the midepigastric and LUQ areas, and the absence of rash. Admission labs: WBC 31.3, Hb 14.2, Hct 43.0, Plt 144, MCV 96, 85% neutrophils, BNP 3117, Na 132, K 3.8, CO2 19, Cl 95, BUN 35, Create 4.62, gluc 133, protein 6.1, alb 2.2, TB 5.5, DB 2.9, Alk phos 159, ALT 47, AST 33, lactate 4.2, troponin I 0.047, random cortisol 93. Strep pneumo and legionella antigens negative. Hepatitis serologies, HIV test, all negative. COVID test by PCR was positive on 6/1/21. She was admitted to the ICU. The day following admission (6/2) CRP 32.4, ESR 106, LDH 399, ferritin 1626, procalcitonin 54.85. CT A/P unremarkable except for bilateral patchy airspace opacities. RUQ US unremarkable, including Dopplers. Echocardiogram (TTE) with LV systolic function mod-severely globally reduced, EF 35%, no valvular disease. Dopplers of LE showed small non-occlusive thrombus in R common femoral. The patient was seen by Infectious Diseases on HD#2 (6/2/21) and IVIG was recommended and administered due to suspicion for MIS-A. She had also been started on cefepime, vancomycin and metronidazole on admission. Blood, urine and resp cultures were negative. She continued to have high norepinephrine requirements, reaching 0.34 mcg/kg/min on 6/3. Due to ongoing shock (cardiogenic vs septic), a Swan-Ganz was placed on 6/4/21. RAP 11 mmHg, RV 38/10 mmHg, PA 40/20 (27) mmHg, PCWP 19 mm Hg, CO 5.75, CI 2.8, SVR 1100, MvO2: 70%. These were consistent with distributive/septic shock rather than cardiogenic.  The patient was able to be weaned from pressors on 6/5/21 at 11:55. Throughout her entire hospital stay, she was comfortable with no respiratory distress, and no abnormalities in mentation. She was transferred to the general medical floor and completed 7 days of antibiotics for empiric sepsis treatment. Labs at discharge on 6/8 showed procalcitonin 5.43, CRP 8.8, LDH 362, Ferritin 1511, TP 5.9, ALT 17, AST 29, Alk phs 158, TB 1.3, Alb 1.6, Create 0.98, WBC 32.5, Hb 7.8, Hct 22.9, Plt 100, neutrophils 70%. She was feeling well without complaints, and will follow up as an outpatient. She was prescribed Xarelto for DVT.
No adverse event; Expired vaccine administered to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) and NO ADVERSE EVENT (No adverse event) in a 37-year-old male patient who received mRNA-1273 (Spikevax) (batch no. O70H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 23-Aug-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 23-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient).    No concomitant medications were reported. Patient age was reported as 37 years and 11 months.  Reportedly, the patient received the Moderna vaccine between 08Apr2022 to 15Dec2022. No treatment medications were reported. Number was reported as 80777027399.
Within the hour of having the injection , I was having a numbness sensation in my right eye and cheek area. Seen in the walk in clinic dx with Bells Palsy, seen in the ER, confirmed Bells palsy. Started prednisone.  Symptoms within 3-4 days at 90%.  Continued prednisone. Nausea, headache, aches on 1/4-1/6 felt better until 1/20- just had extreme back aches , 1/20 eye felt numb again, muscle movement remained the same.  headache, body aches, pins and needles in 3 middle toes on the right side.
Adult patient received Moderna COVID-19 Vaccine for 6 months to 5 years instead of the bivalent booster; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Adult patient received Moderna COVID-19 Vaccine for 6 months to 5 years instead of the bivalent booster) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Adult patient received Moderna COVID-19 Vaccine for 6 months to 5 years instead of the bivalent booster) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Adult patient received Moderna COVID-19 Vaccine for 6 months to 5 years instead of the bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Adult patient received Moderna COVID-19 Vaccine for 6 months to 5 years instead of the bivalent booster).    Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
Doctor found swollen spleen and glands in neck. Chest discomfort with cough. It is still going on.
itching, rash all over, ankles swollen, out of work x 3d, & edema of hands, other joints; MD gave 2 injects & med for itching;
Child developed a hive near injection site of MCV4 and ears turned red and face flushed on 8/20/2020.  Mom reportedly gave child Benadryl as per recommendation of physician and placed an ice pack on the site and it resolved.